Yeah, we have had that discussion here. I feel mo

Yeah, we have had that discussion here. I feel most here are in the exact same camp you are in, taking mental breaks. I'm not sure the best strategy. We are not changing any minds of those that post, but I post for the new investors. Though the discussion their usually has very little to do with leronlimab and their 'facts' are always distorted towards the negative. This board has 65 marks now. I'm hoping it will overtake ihub at some point and we can filter out negative opinions posted as facts. That board has added a couple new followers over the last year. I feel most are probably turned off from all the negative, so they read a few posts on the board and move on. People complaining about some superficial NP issue about how much he is making or whether or not he is buying stock, I guess don't realize they are being counterproductive. New people read NP is lying, dreaming, overpaid, poor communicator, the share price is not going to move until 2020, and simply move on. You would not think reading those posts that the drug is anywhere near passing phase 3, submitting a BLA, and being approved probably later this year, with other indicators in mono, gvhd, cancer right around the corner.

But I will say it is great to have sjacobs on board. Nice to have an accountant also to respond to some crazy math posted mostly by fine. I do myself sometimes, good to have more, especially professionals